Journey Medical Corp
DERMCIK 0001867066
Revenue (TTM)
$61.09M
+11.1% YoY
Q1 Mar 2026
Net Income (TTM)
−$12.41M
+22.1% YoY
Q1 Mar 2026
EPS Diluted (TTM)
−$0.51
+34.7% YoY
Q1 Mar 2026
Gross Margin
62.6%
Q1 Mar 2026
Operating Margin
-15.1%
Q1 Mar 2026
Net Margin
-20.3%
Q1 Mar 2026
Free Cash Flow (TTM)
−$20.9M
Q1 Mar 2026
Cash
$27.22M
Q1 Mar 2026
Total Debt
$22.87M
Q1 Mar 2026
Shares Outstanding
11.56M sh
Q1 Mar 2026